Quarterly report pursuant to Section 13 or 15(d)

Related Party Transactions (Details Textual)

v3.3.0.814
Related Party Transactions (Details Textual) - USD ($)
 3 Months Ended 9 Months Ended 12 Months Ended
Jun. 09, 2015
Feb. 11, 2015
Dec. 09, 2013
Sep. 30, 2015
Sep. 30, 2014
Sep. 30, 2015
Sep. 30, 2014
Dec. 31, 2014
Related Party Transactions (Textual)                
Underwritten offering common stock, Shares           1,044,672    
Stock issued during period value under subscription agreements           $ 2,423,209    
Placement agent [Member]                
Related Party Transactions (Textual)                
Description of receivables of placement agent for services     Agreement entered in on December 9, 2013 included a cash fee equal to 10% of the gross proceeds raised, a non-accountable expense reimbursement equal to 2% of the gross proceeds raised and warrants to purchase shares of the Company's Common Stock.          
Description of warrants receivables by placement     Warrants to purchase shares of the Company's Common Stock in an amount equal to 10% of the shares of common stock issued or issuable.          
Monthly fee for financial advisory services     $ 25,000          
Repayment of amount paid to placement agent           25,000   $ 25,000
Subscription Agreements [Member]                
Related Party Transactions (Textual)                
Amount paid to placement agent $ 400,000              
Underwritten offering common stock, Shares 1,923,078              
Stock issued during period value under subscription agreements $ 5,000,000              
Share price $ 2.6              
IPO [Member]                
Related Party Transactions (Textual)                
Amount paid to placement agent   $ 1,400,000            
Underwritten offering common stock, Shares   4,444,444            
Gross proceeds from public offering   $ 20,000,000            
Net proceeds from public offering   $ 18,500,000            
Memorial Sloan Kettering Cancer Center [Member]                
Related Party Transactions (Textual)                
Maintenance fees       $ 13,539 $ 26,000 $ 200,000 $ 200,000  
Royalty description           Under the agreement, the Company shall pay to MSKCC on a country-by-country basis a royalty of 2% of net sales of all licensed products until the later of: (1) 10 years from the first commercial sale, or (2) when the patents expire.    
Memorial Sloan Kettering Cancer Center [Member] | Clinical Trial Agreement [Member]                
Related Party Transactions (Textual)                
Maintenance fees           $ 13,539   $ 189,537